GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (HKSE:06127) » Definitions » Tax Rate %

Joinn Laboratories (China) Co (HKSE:06127) Tax Rate % : 8.81% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Joinn Laboratories (China) Co Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Joinn Laboratories (China) Co's Tax Expense for the three months ended in Sep. 2024 was HK$10 Mil. Joinn Laboratories (China) Co's Pre-Tax Income for the three months ended in Sep. 2024 was HK$118 Mil. Therefore, Joinn Laboratories (China) Co's Tax Rate % for the quarter that ended in Sep. 2024 was 8.81%.

Joinn Laboratories (China) Co Tax Rate % Historical Data

The historical data trend for Joinn Laboratories (China) Co's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co Tax Rate % Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.39 13.02 13.33 13.45 22.76

Joinn Laboratories (China) Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.95 43.15 6.74 12.66 8.81

Joinn Laboratories (China) Co Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Joinn Laboratories (China) Co's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2023 )/Pre-Tax Income (A: Dec. 2023 )
=126.22/554.491
=22.76 %

Joinn Laboratories (China) Co's Tax Rate % for the quarter that ended in Sep. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Sep. 2024 )/Pre-Tax Income (Q: Sep. 2024 )
=10.421/118.317
=8.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Joinn Laboratories (China) Co Tax Rate % Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Joinn Laboratories (China) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (HKSE:06127) » Definitions » Tax Rate %
Comparable Companies
SZSE:300676 SZSE:300244 SHSE:603108 SZSE:300406 SZSE:300463 SZSE:300685 SHSE:603882 SZSE:300396 SZSE:300639 SZSE:301060 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
603127:China
Address
A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Website
https://www.joinnlabs.com
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Executives
Futu Trustee Limited 2301 Trustee
Ubs Group Ag 2201 Interest of corporation controlled by you
Aggregate Of Abrdn Plc Affiliated Investment Management Entities 2102 Investment manager
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Fidelity Funds 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Abrdn Asia Focus Plc 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Apg Asset Management N.v. 2101 Beneficial owner
Apg Groep N.v. 2101 Beneficial owner
Stichting Pensioenfonds Abp 2101 Beneficial owner

Joinn Laboratories (China) Co Headlines

No Headlines